SeaStar_SM_LogoCard.png
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit
09 oct. 2024 08h30 HE | SeaStar Medical Holding Corporation
DENVER, Oct. 09, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
logo.png
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
08 oct. 2024 08h30 HE | Autonomix Medical, Inc.
Live webcast fireside chat on Tuesday, October 15th at 2:30 PM ET THE WOODLANDS, TX, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a...
logo.png
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
26 sept. 2024 07h30 HE | Autonomix Medical, Inc.
THE WOODLANDS, TX, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to...
SeaStar_SM_LogoCard.png
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial
25 sept. 2024 08h30 HE | SeaStar Medical Holding Corporation
DENVER, Sept. 25, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
logo.png
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum
20 sept. 2024 08h30 HE | Autonomix Medical, Inc.
THE WOODLANDS, TX, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted...
Resize1
Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients
09 sept. 2024 07h00 HE | Autonomix Medical, Inc.
Responders experienced a pain reduction from a pre-procedure pain score of 8 to a pain score of 1.33 at 4-6 weeks post-procedure 60% of patients responded with a mean 6.67 or 83% reduction...
SeaStar_SM_LogoCard.png
SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference
05 sept. 2024 08h00 HE | SeaStar Medical Holding Corporation
DENVER, Sept. 05, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
SeaStar_SM_LogoCard.png
SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt
04 sept. 2024 08h30 HE | SeaStar Medical Holding Corporation
DENVER, Sept. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical), a commercial-stage medical device company developing proprietary solutions to reduce...
logo.png
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference
27 août 2024 08h30 HE | Autonomix Medical, Inc.
THE WOODLANDS, TX, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to...
logo.png
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress
21 août 2024 08h30 HE | Autonomix Medical, Inc.
Presentation to discuss latest developments in future AI applications in interventional radiology, specifically highlighting the early results from the Company’s ongoing proof-of-concept (PoC) human...